Poly Medicure Limited

NSE:POLYMED.NS

2781 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 13,757.96311,152.3049,168.8797,750.3536,692.6165,910.0895,073.5064,476.9984,071.6123,838.3353,146.1482,550.4412,170.2791,729.5131,371.9081,122.236883.817848.969
Cost of Revenue 7,924.4584,058.7524,332.2553,364.6272,856.4462,720.9432,259.5312,015.011,857.8721,809.3611,394.1311,130.242755.972900.553701.609590.846526.657502.417
Gross Profit 5,833.5057,093.5524,836.6244,385.7263,836.173,189.1462,813.9752,461.9882,213.742,028.9741,752.0171,420.1991,414.307828.96670.299531.39357.16346.552
Gross Profit Ratio 0.4240.6360.5280.5660.5730.540.5550.550.5440.5290.5570.5570.6520.4790.4890.4740.4040.408
Reseach & Development Expenses 189.602178.025187.711131.445119.424101.49100.47890.33887.11384.66659.23839.94925.83500000
General & Administrative Expenses 2,482.338175.733171.63168.306171.809156.824110.025121.34588.06778.31103.87244.3020185.303165.414191.37397.55479.33
Selling & Marketing Expenses 33.905205.118150.766126.279147.183161.788128.027157.469117.889136.52595.00978.177000000
SG&A 2,700.952380.851322.396294.585318.992318.612238.052278.814205.956214.835198.881122.4790185.303165.414191.37397.55479.33
Other Expenses 587.481361.85435.4612.2598.70528.5188.5196.7479.4527.3374.1181.6541,032.643366.3295.33348.021140.45722.866
Operating Expenses 2,890.5545,011.3733,195.0322,683.1252,565.2882,223.0571,880.7491,753.5161,538.1971,355.8051,091.528858.4991,058.478551.603460.747419.408238.011220.057
Operating Income 2,942.9512,087.5421,596.2461,668.5681,239.714936.95933.226624.573588.944787.965631.488330.509288.383238.652175.449111.982119.149126.495
Operating Income Ratio 0.2140.1870.1740.2150.1850.1590.1840.140.1450.2050.2010.130.1330.1380.1280.10.1350.149
Total Other Income Expenses Net 474.472287.372356.203131.97217.51963.79534.28937.1322.94519425.038-58.821-67.446-38.705-34.104-45.941-38.853-23.483
Income Before Tax 3,417.4232,374.9141,952.4491,800.541,257.2331,000.745967.515717.092650.416847.519631.488330.509288.383238.652175.44866.04180.296103.012
Income Before Tax Ratio 0.2480.2130.2130.2320.1880.1690.1910.160.160.2210.2010.130.1330.1380.1280.0590.0910.121
Income Tax Expense 860.094582.089487.389441.796298.454346.755261.576199.77175.687230.99191.18897.75896.26922.50318.0317.1884.07420.305
Net Income 2,582.5971,792.8251,465.061,358.744958.779653.99705.939523.193482.679623.228450.938242.297194.693216.715157.9959.61676.95482.707
Net Income Ratio 0.1880.1610.160.1750.1430.1110.1390.1170.1190.1620.1430.0950.090.1250.1150.0530.0870.097
EPS 26.2418.6915.2815.2510.867.4186.255.477.065.122.752.212.461.790.680.880.96
EPS Diluted 26.2218.6715.2715.2410.867.4186.255.477.065.112.752.212.461.790.680.830.95
EBITDA 3,582.2163,034.9682,434.5072,319.7341,837.8731,485.2781,353.3261,014.643943.007900.48751.787519.938473.23371.593288.442182.108176.382165.642
EBITDA Ratio 0.260.2720.2660.2990.2750.2510.2670.2270.2320.2350.2390.2040.2180.2150.210.1620.20.195